F
Fatma Şebnem Erdinç
Researcher at Turkish Ministry of Health
Publications - 2
Citations - 634
Fatma Şebnem Erdinç is an academic researcher from Turkish Ministry of Health. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 1, co-authored 2 publications receiving 72 citations. Previous affiliations of Fatma Şebnem Erdinç include University of Health Science.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
Mine Durusu Tanriover,Hamdi Levent Doganay,Murat Akova,Hatice Rahmet Güner,Alpay Azap,Sıla Akhan,Sukran Kose,Fatma Şebnem Erdinç,Emin Halis Akalin,Ömer Tabak,Hüsnü Pullukçu,Özgür Batum,Serap Şimşek Yavuz,Özge Turhan,Mustafa Taner Yildirmak,İftihar Köksal,Yeşim Taşova,Volkan Korten,Gürdal Yilmaz,Gürdal Yilmaz,Mustafa Kemal Çelen,Sedat Altin,Ilhami Çelik,Yasar Bayindir,Ilkay Karaoglan,Aydin Yilmaz,Aydin Yilmaz,Aykut Ozkul,Hazal Gür,Serhat Ünal +29 more
TL;DR: CoronaVac as discussed by the authors has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral response against SARS-CoV-2.
Journal ArticleDOI
Oxidant and antioxidant balance in patients with COVID-19.
Kubra Aykac,Yasemin Ozsurekci,Burcu Ceylan Cura Yayla,Sibel Laçinel Gürlevik,Pembe Derin Oygar,Nuriye Boduc Bolu,Medine Aysin Tasar,Fatma Şebnem Erdinç,Gulay Tuncer Ertem,Salim Neselioglu,Ozcan Erel,Ali Bülent Cengiz,Mehmet Ceyhan +12 more
TL;DR: In this paper, the authors evaluated the contribution of balance between oxidant and antioxidant mechanisms to coronavirus disease 2019 (COVID-19), a devastating pandemic caused by viral infection.